EN DE
STOCK COMPARISON

GE HealthCare Technologies vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how GE HealthCare Technologies (GEHC) and Abbott Laboratories (ABT) compare, as of Aug 14, 2026.

As of Aug 14, 2026, Fair Value Calculator sees GE HealthCare Technologies as the less overvalued of the two: GE HealthCare Technologies trades at $73.79 versus a fair value of $64.13 (-13%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).
GE HealthCare Technologies
GEHC · USD · Health Care
-13%
upside to fair value
overvalued
Price$73.79
Fair Value$64.13
Quality54/100
Abbott Laboratories
ABT · USD · Health Care
-33%
upside to fair value
overvalued
Price$111
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

GE HealthCare TechnologiesAbbott Laboratories
Valuation
17.6×P/E (TTM)27.7×
1.37×P/S (TTM)3.89×
2.77×P/B3.36×
9.6×EV/EBITDA15.1×
1.74×PEG1.47×
0.2%Dividend yield—
$0.14Dividend per share—
Profitability
9%Net margin14%
11%Operating margin13%
19%Return on equity12%
5%Return on assets6%
Growth
7%Revenue growth (YoY)8%
4.0%Avg. growth/yr (3Y)0.5%
3.7%Avg. growth/yr (5Y)5.1%
Balance & size
0.92×Debt / equity0.19×
$29BMarket cap$175B
healthyGrowth qualityhealthy

Abbott Laboratories leads: 6 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

GE HealthCare Technologiesof which business quality 51 · market factors 47 Abbott Laboratoriesof which business quality 66 · market factors 53
ProfitabilityMargins and returns on capital today
48
50
Quality GrowthAre margins and returns improving?
38
47
CashflowEarnings quality: real cash, not paper profit
45
71
Fin. StrengthBalance sheet, leverage, solvency risk
39
80
InvestmentDisciplined investing over empire-building
76
65
Low VolatilityCalm price path (market factor)
64
83
MomentumPrice trend over the last 3–12 months (market factor)
39
43
52W MomentumDistance to the 52-week high (market factor)
41
38
Net IssuanceBuybacks instead of dilution
78
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

GE HealthCare Technologies

DCF Models$63.13
Earnings-Based$41.51
Dividend Discount$2.08
Multiples$84.86
Asset-Based$15.29
Growth DCF$50.97
Economic Profit$45.01
Growth Earnings$81.55

17 of 25 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

GE HealthCare Technologies
Bear $36.80Fair Value $64.13Bull $106
$73.79 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$111 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

GE HealthCare Technologies · Health Care

Quality score54 · above median
Fair value upside-13% · above median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-33% · below median

Bottom line

As of Aug 14, 2026, Fair Value Calculator sees GE HealthCare Technologies as the less overvalued of the two: GE HealthCare Technologies trades at $73.79 versus a fair value of $64.13 (-13%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
GE HealthCare Technologies · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to GE HealthCare Technologies

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Abbott Laboratories

UnitedHealth Group vs Abbott LaboratoriesUnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs Amgen
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.